Internal and Emergency Medicine
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonates
Study of 60 peopleDenosumab
Papers on alendronic acid
2 papers
Saturday, August 3
Monday, May 8
The Lancet Regional Health Europe
Explaining declining hip fracture rates in Norway: a population-based modelling study
Computational studyHip fracture